130 related articles for article (PubMed ID: 34155850)
1. Circulating Endothelial Progenitor Cells in Patients with Heart Failure with Preserved versus Reduced Ejection Fraction.
Kakzanov Y; Sevilya Z; Veturi M; Goldman A; Lev EI
Isr Med Assoc J; 2021 Jun; 23(6):364-368. PubMed ID: 34155850
[TBL] [Abstract][Full Text] [Related]
2. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
[TBL] [Abstract][Full Text] [Related]
3. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
Berezin AE; Kremzer AA; Martovitskaya YV; Berezina TA; Gromenko EA
EBioMedicine; 2016 Feb; 4():86-94. PubMed ID: 26981573
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
[TBL] [Abstract][Full Text] [Related]
6. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
[TBL] [Abstract][Full Text] [Related]
7. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
8. Decreased circulating endothelial progenitor cell levels in patients with heart failure with preserved ejection fraction.
Chiang CH; Huang PH; Leu HB; Hsu CY; Wang KF; Chen JW; Lin SJ
Cardiology; 2013; 126(3):191-201. PubMed ID: 24051936
[TBL] [Abstract][Full Text] [Related]
9. Flow-Mediated Vasodilation and Reactive Hyperemia Index in Heart Failure with Reduced or Preserved Ejection Fraction.
Waku R; Tokoi S; Toyoda S; Kitahara K; Naganuma J; Yazawa H; Sakuma M; Abe S; Nakajima T; Inoue T
Tohoku J Exp Med; 2020 Sep; 252(1):85-93. PubMed ID: 32893258
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study.
Alba AC; Lalonde SD; Rao V; Walter SD; Guyatt GH; Ross HJ
Can J Cardiol; 2013 Dec; 29(12):1657-64. PubMed ID: 24054922
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.
Premer C; Blum A; Bellio MA; Schulman IH; Hurwitz BE; Parker M; Dermarkarian CR; DiFede DL; Balkan W; Khan A; Hare JM
EBioMedicine; 2015 May; 2(5):467-75. PubMed ID: 26137590
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality.
Van Craenenbroeck EM; Denollet J; Paelinck BP; Beckers P; Possemiers N; Hoymans VY; Vrints CJ; Conraads VM
Clin Sci (Lond); 2009 Jul; 117(4):165-72. PubMed ID: 19173675
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
14. Circulating hematopoietic progenitor cells are decreased in COPD.
Janssen WJ; Yunt ZX; Muldrow A; Kearns MT; Kloepfer A; Barthel L; Bratton DL; Bowler RP; Henson PM
COPD; 2014 Jun; 11(3):277-89. PubMed ID: 24182349
[TBL] [Abstract][Full Text] [Related]
15. Mobilization of endothelial progenitor cell in patients with acute ischemic stroke.
Deng Y; Wang J; He G; Qu F; Zheng M
Neurol Sci; 2018 Mar; 39(3):437-443. PubMed ID: 29147957
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Mineralocorticoid Receptor Antagonists on Recruitment and Function of Endothelial Progenitor Cells in Patients with Congestive Heart Failure.
Levi A; Leshem-Lev D; Weissler-Snir A; Hasin T; Mats I; Murninkas D; Kornowski R; Lev EI; Ben-Gal T
Isr Med Assoc J; 2018 Apr; 20(4):233-238. PubMed ID: 29629731
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis.
Lev EI; Leshem-Lev D; Mager A; Vaknin-Assa H; Harel N; Zimra Y; Bental T; Greenberg G; Dvir D; Solodky A; Assali A; Battler A; Kornowski R
Eur Heart J; 2010 Nov; 31(21):2625-32. PubMed ID: 20543191
[TBL] [Abstract][Full Text] [Related]
18. Reduced Levels of Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Heart Failure with Reduced Ejection Fraction.
Lopes J; Teixeira M; Cavalcante S; Gouveia M; Duarte A; Ferreira M; Simões MI; Conceição M; Ribeiro IP; Gonçalves AC; Schmidt C; de Jesus BB; Almeida R; Viamonte S; Santos M; Ribeiro F
Arch Med Res; 2022 Apr; 53(3):289-295. PubMed ID: 35183379
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial progenitor cells in patients with dysfunctional versus normally functioning congenitally bicuspid aortic valves.
Vaturi M; Perl L; Leshem-Lev D; Dadush O; Bental T; Shapira Y; Yedidya I; Greenberg G; Kornowski R; Sagie A; Battler A; Lev EI
Am J Cardiol; 2011 Jul; 108(2):272-6. PubMed ID: 21550575
[TBL] [Abstract][Full Text] [Related]
20. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
